Allergenicity and safety of recombinant human C1 esterase inhibitor in patients with allergy to rabbit or cow's milk-Reference-Cited by-同舟云学术

Allergenicity and safety of recombinant human C1 esterase inhibitor in patients with allergy to rabbit or cow's milk

Published:2016-08 Issue:2 Volume:138 Page:476-481.e1
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

van den Elzen Mignon T.,van Os-Medendorp Harmieke,Röckmann-Helmbach Heike,van Hoffen Els,Lebens Ans F.M.,van Doorn Helma,Klemans Rob J.B.,Bruijnzeel-Koomen Carla A.F.M.,Hack C. Erik,Kaufman Leonard,Relan Anurag,Knulst André C.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference20 articles.

1. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group;Cicardi;Allergy,2014

2. Conestat alfa for the treatment of angioedema attacks;Davis;Ther Clin Risk Manag,2011

3. Immunosafety of recombinant human C1-inhibitor in hereditary angioedema: evaluation of IgE antibodies;Hack;Clin Drug Investig,2013

4. rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency;Varga;Expert Rev Clin Immunol,2011

5. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond;Agostoni;J Allergy Clin Immunol,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification, Characterization, and the Determination of Process-related Impurities in Minodronic Acid Bulk Drug;Current Pharmaceutical Analysis;2022-03

2. Therapeutic management of hereditary angioedema: past, present, and future;Balkan Medical Journal;2021-03-10

3. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema;Expert Review of Clinical Immunology;2018-09-02